Illumina, Inc. Share Price

Illumina, Inc. Share Price

NASDAQ: ILMN | Large Cap
$236.09
-$53.08 (-18.35%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Illumina, Inc. Stock Performance

Open
$256.09
Prev. Close
$289.17
Circuit Range
N/A
Day Range
$231.43 - $256.09
Year Range
$94.22 - $308.57
Volume
4,07,530
Average Traded
$239.18

Illumina, Inc. Share Price Today

As of 1 November 2026, Illumina, Inc.'s share price is $236.09. The stock opened at $256.09, compared to its previous close of $289.17. During today's trading session, Illumina, Inc.'s share price traded between $231.43 and $256.09, with an average price of $243.76. Over the past 52 weeks, the stock has recorded a high of $308.57 and a low of $94.22. In terms of performance, Illumina, Inc.'s share price has risen by 86.40% over the last six months and is up 91.09% on a year-on-year basis.

Illumina, Inc. Share Price Chart

Line chart of the Illumina, Inc. price trend over the selected period. The price fell overall, ranging from 231.43 to 250.83, ending at 236.09.
$231.43$256.09
L
Show Current Price
H

Illumina, Inc. Stock Fundamentals & Key Indicators

Market Cap
$36.59B
PE Ratio (TTM)
39.82
Dividend Yield
0.00%
EPS (TTM)
$5.93
Revenue (TTM)
$4.34T
Return On Equity (TTM)
28.46%
Profit Margin
19.57%
Debt to Equity
0.57
Quarterly Earnings Growth YoY
-34.13%

Illumina, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1159.00$1091.00$1159.00$1129.00
Net Profit$334.00$134.00$207.00$220.00
Net Profit Margin28.82%12.28%17.86%19.49%
Income ChangeN/A-59.88%54.48%6.28%

Illumina, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$4584.00$4504.00$4372.00$4343.00
Net Profit-$4404.00-$1161.00-$1223.00$850.00
Net Profit Margin-96.07%-25.78%-27.97%19.57%
Income ChangeN/A73.64%-5.34%169.50%

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$273.14
$235.95
-13.90%
Sep 2026
$212.20
$274.03
+20.38%
Aug 2026
$205.66
$227.65
+10.99%
Jul 2026
$176.67
$205.10
+16.65%
Jun 2026
$161.40
$175.83
+7.89%
May 2026
$132.70
$162.97
+28.67%
Apr 2026
$123.51
$126.66
+2.78%
Mar 2026
$132.25
$123.23
-8.37%
Feb 2026
$143.25
$134.49
-7.08%
Jan 2026
$131.01
$144.75
+10.38%
Dec 2025
$130.06
$131.13
-0.24%
Nov 2025
$121.11
$131.44
+6.39%

ILMN Share Price FAQs